Evidence map›Paper›PMID 36312905›Full record

ArticlePlastic and reconstructive surgery. Global open2022

Sickle Cell Disease Association with Premature Suture Fusion in Young Children.

Monica Manrique, Sara Toro-Tobon, Yusuf Bade, Juliana Paredes-Gutierrez, Esperanza Mantilla-Rivas, Md Sohel Rana, Albert K Oh, Gary F Rogers

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Monica ManriqueDivision of Plastic and Reconstructive Surgery, Children's National Hospital, Washington, D.C.
Sara Toro-TobonDivision of Plastic and Reconstructive Surgery, Children's National Hospital, Washington, D.C.
Yusuf BadeDivision of Plastic and Reconstructive Surgery, Children's National Hospital, Washington, D.C.
Juliana Paredes-GutierrezDivision of Plastic and Reconstructive Surgery, Children's National Hospital, Washington, D.C.
Esperanza Mantilla-RivasDivision of Plastic and Reconstructive Surgery, Children's National Hospital, Washington, D.C.
Md Sohel RanaDivision of Plastic and Reconstructive Surgery, Children's National Hospital, Washington, D.C.
Albert K OhDivision of Plastic and Reconstructive Surgery, Children's National Hospital, Washington, D.C.
Gary F RogersDivision of Plastic and Reconstructive Surgery, Children's National Hospital, Washington, D.C.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sickle cell disease (SCD) leads to the formation of an atypical hemoglobin tetramer with reduced capacity to carry oxygen. Although correlation between SCD and craniosynostosis (CS) has been mentioned, these are mostly small series or case reports. This article aimed to study any correlation between these entities in a large pediatric population. Methods: We retrospectively reviewed head CT scans of SCD patients from 0 to 8 years of age who required a CT for issues unrelated to their head shape between 2012 and 2020. We excluded patients with known history of CS or any CS-related syndrome, hydrocephalus, shunt placement, history of cranial surgery, or any reported cerebral or cranial shape abnormality. Results: Ninety-four CT scans were analyzed. The mean age at imaging was 4.48 ± 2.30 years. CS prevalence in this cohort was 19.1%. Analysis between independent variables and patients with +CS showed that SCD-associated vasculopathy, first-degree relatives with SCD, and the use of folic acid had a statistically significant association with CS development. Conclusions: Approximately 20% of pediatric patients with SCD developed CS. This association was higher in those patients who had a family history of SCD, used folic acid, and had SCD-associated vasculopathy. While the clinical impact of these findings needs more extensive study, centers that manage patients with SCD should be aware of the relatively high concordance of these diagnoses, vigilantly monitor head shape and growth parameters, and understand the potential risks associated with unidentified or untreated CS.

Identifiers

PMID36312905
PMCPMC9612952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.